Free Trial

Blend Labs (BLND) Financials

Blend Labs logo
$3.23 -0.08 (-2.42%)
Closing price 03:59 PM Eastern
Extended Trading
$3.22 0.00 (-0.15%)
As of 06:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Blend Labs

Annual Income Statements for Blend Labs

This table shows Blend Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-81 -75 -171 -769 -185 -60
Consolidated Net Income / (Loss)
-81 -75 -169 -764 -180 -43
Net Income / (Loss) Continuing Operations
-81 -75 -169 -764 -180 -43
Total Pre-Tax Income
-81 -75 -208 -766 -180 -43
Total Operating Income
-82 -75 -197 -746 -156 -50
Total Gross Profit
31 62 116 90 81 91
Total Revenue
51 96 234 235 157 162
Operating Revenue
51 96 234 235 157 162
Total Cost of Revenue
20 34 119 146 76 71
Operating Cost of Revenue
20 34 119 146 76 71
Total Operating Expenses
113 137 313 836 237 140
Selling, General & Admin Expense
27 30 129 139 71 51
Marketing Expense
38 51 84 85 60 36
Research & Development Expense
49 56 92 138 82 46
Amortization Expense
- 0.00 8.14 8.41 0.00 0.00
Impairment Charge
- 0.00 0.00 450 0.00 0.00
Restructuring Charge
- 0.00 0.00 15 25 7.47
Total Other Income / (Expense), net
0.28 0.70 -11 -20 -24 6.31
Interest Expense
- 0.00 11 25 31 6.75
Other Income / (Expense), net
0.28 0.70 0.49 4.92 7.25 13
Income Tax Expense
0.01 0.03 -39 -2.24 0.09 0.11
Preferred Stock Dividends Declared
- 0.00 1.43 0.00 0.00 11
Net Income / (Loss) Attributable to Noncontrolling Interest
- 0.00 0.77 4.80 5.44 6.19
Basic Earnings per Share
($2.49) ($1.89) ($1.30) ($3.28) ($0.76) ($0.24)
Weighted Average Basic Shares Outstanding
32.78M 39.41M 131.99M 234.16M 245.21M 253.92M
Diluted Earnings per Share
($2.49) ($1.89) ($1.30) ($3.28) ($0.76) ($0.24)
Weighted Average Diluted Shares Outstanding
32.78M 39.41M 131.99M 234.16M 245.21M 253.92M
Weighted Average Basic & Diluted Shares Outstanding
- - 232.41M 242.85M 252.05M 259.66M

Quarterly Income Statements for Blend Labs

This table shows Blend Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
-134 -83 -67 -43 -43 -32 -22 -24 -8.25 -6.51
Consolidated Net Income / (Loss)
-133 -81 -66 -41 -42 -30 -21 -19 -2.63 -0.71
Net Income / (Loss) Continuing Operations
-133 -81 -66 -41 -42 -30 -21 -19 -2.63 -0.71
Total Pre-Tax Income
-133 -81 -66 -41 -42 -30 -21 -19 -2.61 -0.68
Total Operating Income
-130 -75 -61 -37 -36 -22 -21 -13 -13 -1.79
Total Gross Profit
21 14 16 23 22 20 18 22 26 25
Total Revenue
55 43 37 43 41 36 35 40 45 41
Operating Revenue
55 43 37 43 41 36 35 40 45 41
Total Cost of Revenue
34 28 21 19 19 16 17 19 19 17
Operating Cost of Revenue
34 28 21 19 19 16 17 19 19 17
Total Operating Expenses
151 90 77 60 58 42 39 35 39 27
Selling, General & Admin Expense
32 33 21 20 16 15 14 13 13 11
Marketing Expense
21 20 18 16 14 12 10 9.37 9.88 6.58
Research & Development Expense
34 33 26 22 19 14 14 13 10 8.86
Restructuring Charge
5.94 2.96 13 2.35 9.12 0.69 0.98 0.21 6.17 0.12
Total Other Income / (Expense), net
-2.88 -5.81 -4.69 -4.72 -5.58 -8.58 0.55 -6.06 11 1.11
Other Income / (Expense), net
3.28 1.54 2.88 3.23 2.63 -1.50 5.65 -4.41 11 1.11
Income Tax Expense
0.01 0.48 0.07 0.05 0.04 -0.07 0.04 0.02 0.02 0.03
Preferred Stock Dividends Declared
7.85 -46 2.06 0.00 0.00 -2.06 1.46 2.66 4.05 2.71
Net Income / (Loss) Attributable to Noncontrolling Interest
-6.62 48 -0.78 1.33 1.39 3.49 0.01 1.51 1.58 3.09
Basic Earnings per Share
($0.57) ($0.33) ($0.28) ($0.18) ($0.18) ($0.12) ($0.09) ($0.09) ($0.03) ($0.03)
Weighted Average Basic Shares Outstanding
235.27M 234.16M 241.44M 244.26M 246.41M 245.21M 250.93M 253.07M 254.91M 253.92M
Diluted Earnings per Share
($0.57) ($0.33) ($0.28) ($0.18) ($0.18) ($0.12) ($0.09) ($0.09) ($0.03) ($0.03)
Weighted Average Diluted Shares Outstanding
235.27M 234.16M 241.44M 244.26M 246.41M 245.21M 250.93M 253.07M 254.91M 253.92M
Weighted Average Basic & Diluted Shares Outstanding
237.70M 242.85M 243.85M 245.89M 248.20M 252.05M 252.38M 254.24M 255.93M 259.66M

Annual Cash Flow Statements for Blend Labs

This table details how cash moves in and out of Blend Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
8.21 18 172 -89 -91 11
Net Cash From Operating Activities
-59 -65 -128 -190 -128 -13
Net Cash From Continuing Operating Activities
-59 -65 -128 -190 -128 -13
Net Income / (Loss) Continuing Operations
-81 -75 -169 -764 -180 -43
Consolidated Net Income / (Loss)
-81 -75 -169 -764 -180 -43
Depreciation Expense
4.76 3.99 11 11 2.46 2.29
Amortization Expense
2.27 6.00 9.63 11 9.24 7.28
Non-Cash Adjustments To Reconcile Net Income
11 11 74 559 45 19
Changes in Operating Assets and Liabilities, net
4.06 -11 -52 -7.35 -4.25 1.89
Net Cash From Investing Activities
-66 -7.92 -634 99 127 45
Net Cash From Continuing Investing Activities
-66 -7.92 -634 99 127 45
Purchase of Property, Plant & Equipment
-0.58 -1.32 -1.89 -2.07 -0.59 -9.84
Purchase of Investments
-151 -174 -352 -146 -236 -102
Divestitures
- - - 0.00 0.00 9.08
Sale and/or Maturity of Investments
86 167 125 247 366 153
Other Investing Activities, net
0.00 0.00 -3.00 0.00 -2.50 -5.28
Net Cash From Financing Activities
133 91 934 2.22 -91 -21
Net Cash From Continuing Financing Activities
133 91 934 2.22 -91 -21
Repayment of Debt
-0.07 0.00 2.88 0.00 -85 -145
Repurchase of Common Equity
-0.05 - - 0.00 0.00 -9.48
Issuance of Preferred Equity
126 76 310 0.00 0.00 149
Issuance of Common Equity
0.00 10 367 -0.39 0.00 0.00
Other Financing Activities, net
1.65 4.51 35 2.61 -5.90 -16
Effect of Exchange Rate Changes
- 0.00 -0.01 -0.12 -0.03 -0.01
Cash Interest Paid
0.00 0.00 6.43 25 28 6.15
Cash Income Taxes Paid
0.01 0.03 0.88 0.28 0.11 0.08

Quarterly Cash Flow Statements for Blend Labs

This table details how cash moves in and out of Blend Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-18 9.82 -78 -4.26 45 -54 54 -39 9.59 -13
Net Cash From Operating Activities
-50 -47 -47 -34 -26 -21 -3.87 -6.67 2.08 -4.59
Net Cash From Continuing Operating Activities
-50 -47 -47 -34 -26 -21 -3.87 -6.67 2.08 -4.59
Net Income / (Loss) Continuing Operations
-133 -81 -66 -41 -42 -30 -21 -19 -2.63 -0.71
Consolidated Net Income / (Loss)
-133 -81 -66 -41 -42 -30 -21 -19 -2.63 -0.71
Depreciation Expense
0.93 0.61 0.63 0.63 0.60 0.61 0.56 0.56 0.68 0.49
Amortization Expense
2.91 2.94 2.52 2.33 2.31 2.09 1.65 1.27 3.88 0.49
Non-Cash Adjustments To Reconcile Net Income
83 28 15 12 7.76 9.66 3.42 13 -2.90 5.74
Changes in Operating Assets and Liabilities, net
-5.00 2.20 1.35 -7.42 5.04 -3.22 11 -1.72 3.04 -11
Net Cash From Investing Activities
31 57 -29 31 72 53 61 -25 12 -1.89
Net Cash From Continuing Investing Activities
31 57 -29 31 72 53 61 -25 12 -1.89
Purchase of Property, Plant & Equipment
-0.45 -0.46 -0.30 -0.17 -0.03 -0.08 -1.96 -1.87 -3.43 -2.58
Purchase of Investments
-46 -49 -186 -8.75 -8.32 -33 -48 -28 -20 -5.61
Sale and/or Maturity of Investments
78 107 158 40 80 89 111 5.00 26 11
Other Investing Activities, net
- - - - - -2.50 - - - -5.00
Net Cash From Financing Activities
0.94 0.04 -2.42 -1.09 -1.33 -86 -3.19 -7.32 -4.23 -6.32
Net Cash From Continuing Financing Activities
0.94 0.04 -2.42 -1.09 -1.33 -86 -3.19 -7.32 -4.23 -6.32
Other Financing Activities, net
0.94 0.04 -2.42 -1.09 -1.33 -1.07 -3.19 -3.12 -3.83 -6.32

Annual Balance Sheets for Blend Labs

This table presents Blend Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Total Assets
216 1,112 433 206 178
Total Current Assets
186 613 396 170 135
Cash & Equivalents
41 213 124 31 42
Short-Term Investments
111 334 230 106 56
Accounts Receivable
15 34 23 18 17
Prepaid Expenses
19 32 19 15 19
Plant, Property, & Equipment, net
4.59 6.16 5.74 3.95 12
Total Noncurrent Assets
25 493 31 32 31
Intangible Assets
1.21 173 2.13 2.11 2.08
Other Noncurrent Operating Assets
24 33 29 30 28
Total Liabilities & Shareholders' Equity
216 1,112 433 206 178
Total Liabilities
52 302 269 179 40
Total Current Liabilities
35 60 35 32 39
Accounts Payable
3.44 6.16 1.26 2.17 2.42
Current Deferred Revenue
14 8.07 8.70 8.98 19
Current Employee Benefit Liabilities
9.06 18 10 5.56 3.98
Other Current Liabilities
8.91 28 15 15 13
Total Noncurrent Liabilities
17 242 233 148 1.38
Long-Term Debt
0.00 214 217 138 0.00
Other Noncurrent Operating Liabilities
17 28 17 9.21 1.38
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
0.00 36 41 46 194
Total Equity & Noncontrolling Interests
163 775 123 -19 -56
Total Preferred & Common Equity
163 775 123 -19 -56
Total Common Equity
-222 775 123 -19 -56
Common Stock
51 1,218 1,287 1,322 1,328
Retained Earnings
-273 -443 -1,163 -1,342 -1,385
Accumulated Other Comprehensive Income / (Loss)
-0.01 -0.81 -0.71 0.44 0.60

Quarterly Balance Sheets for Blend Labs

This table presents Blend Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
493 385 350 318 202 185 186
Total Current Assets
454 350 309 283 160 143 146
Cash & Equivalents
114 46 35 85 85 45 55
Short-Term Investments
286 261 231 160 44 67 62
Accounts Receivable
28 20 21 20 18 20 16
Prepaid Expenses
25 23 22 19 13 10 14
Plant, Property, & Equipment, net
6.04 5.41 4.97 4.45 5.98 7.62 9.72
Total Noncurrent Assets
33 30 36 31 36 35 30
Intangible Assets
2.13 2.12 2.12 2.11 2.10 2.10 2.09
Other Noncurrent Operating Assets
31 28 34 29 34 33 28
Total Liabilities & Shareholders' Equity
493 385 350 318 202 185 186
Total Liabilities
278 272 266 267 190 48 47
Total Current Liabilities
44 40 35 37 43 42 45
Accounts Payable
2.55 1.93 3.15 2.12 1.90 1.08 1.86
Current Deferred Revenue
9.96 13 12 10 22 21 20
Current Employee Benefit Liabilities
14 11 4.74 9.87 5.19 3.23 6.05
Other Current Liabilities
18 14 15 15 14 16 17
Total Noncurrent Liabilities
234 232 231 230 147 6.74 2.25
Long-Term Debt
216 218 218 219 139 0.00 0.00
Capital Lease Obligations
- - - - 6.40 5.17 0.96
Other Noncurrent Operating Liabilities
18 15 13 11 2.06 1.57 1.29
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
39 42 43 45 48 183 188
Total Equity & Noncontrolling Interests
176 71 41 6.29 -36 -45 -50
Total Preferred & Common Equity
176 71 41 6.29 -36 -45 -50
Total Common Equity
176 71 41 6.29 -36 -45 -50
Common Stock
1,260 1,300 1,312 1,318 1,326 1,336 1,334
Retained Earnings
-1,082 -1,228 -1,270 -1,311 -1,362 -1,382 -1,384
Accumulated Other Comprehensive Income / (Loss)
-2.16 0.10 -0.69 -0.40 0.35 0.30 0.77

Annual Metrics and Ratios for Blend Labs

This table displays calculated financial ratios and metrics derived from Blend Labs' official financial filings.

Metric 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - -
Revenue Growth
0.00% 89.51% 144.19% 0.30% -33.31% 3.30%
EBITDA Growth
0.00% 13.19% -173.26% -307.42% 80.91% 80.33%
EBIT Growth
0.00% 8.41% -163.77% -276.75% 79.90% 75.46%
NOPAT Growth
0.00% 7.87% -161.97% -278.31% 79.06% 68.24%
Net Income Growth
0.00% 8.39% -126.68% -351.58% 76.45% 75.86%
EPS Growth
0.00% 24.10% 31.22% -152.31% 76.83% 68.42%
Operating Cash Flow Growth
0.00% -10.31% -96.12% -49.34% 32.98% 89.78%
Free Cash Flow Firm Growth
0.00% 0.00% -841.36% 88.13% -55.02% 58.99%
Invested Capital Growth
0.00% 0.00% 4,071.01% -94.43% 6.71% 38.25%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -13.97% -4.09% 3.38%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -2.42% 26.46% 43.71%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -1.91% 25.22% 38.29%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -2.09% 25.44% 28.81%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -1.32% 22.11% 40.59%
EPS Q/Q Growth
0.00% 0.00% 0.00% -0.31% 21.65% 27.27%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -33.73% -2.26% 17.27% 55.25%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 21.47% 1.99%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -12.08% 13.03% 71.90%
Profitability Metrics
- - - - - -
Gross Margin
61.42% 64.29% 49.46% 38.12% 51.73% 55.88%
EBITDA Margin
-146.85% -67.27% -75.27% -305.76% -87.52% -16.66%
Operating Margin
-161.28% -78.40% -84.11% -317.25% -99.60% -30.63%
EBIT Margin
-160.72% -77.68% -83.90% -315.16% -94.98% -22.57%
Profit (Net Income) Margin
-160.75% -77.70% -72.13% -324.75% -114.69% -26.80%
Tax Burden Percent
100.02% 100.03% 81.31% 99.71% 100.05% 100.25%
Interest Burden Percent
100.00% 100.00% 105.73% 103.34% 120.68% 118.45%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -921.31% -56.51% -207.36% -398.13% -102.82%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -892.46% -43.71% -104.76% -294.37% -84.92%
Return on Net Nonoperating Assets (RNNOA)
0.00% 829.95% 21.78% 50.60% 209.65% 50.07%
Return on Equity (ROE)
0.00% -91.37% -34.73% -156.76% -188.49% -52.75%
Cash Return on Invested Capital (CROIC)
0.00% -1,121.31% -247.15% -28.46% -404.63% -134.92%
Operating Return on Assets (OROA)
0.00% -34.57% -29.63% -95.94% -46.64% -19.04%
Return on Assets (ROA)
0.00% -34.59% -25.47% -98.86% -56.32% -22.61%
Return on Common Equity (ROCE)
0.00% 124.12% -19.71% -144.42% -102.63% 24.22%
Return on Equity Simple (ROE_SIMPLE)
0.00% -45.68% -21.83% -620.12% 934.78% 77.04%
Net Operating Profit after Tax (NOPAT)
-57 -53 -138 -522 -109 -35
NOPAT Margin
-112.90% -54.88% -58.88% -222.08% -69.72% -21.44%
Net Nonoperating Expense Percent (NNEP)
0.00% -28.85% -12.81% -102.60% -103.76% -17.90%
Return On Investment Capital (ROIC_SIMPLE)
- - - -153.64% -91.83% 61.63%
Cost of Revenue to Revenue
38.58% 35.71% 50.54% 61.88% 48.27% 44.12%
SG&A Expenses to Revenue
52.47% 31.35% 54.93% 59.15% 45.07% 31.20%
R&D to Revenue
95.91% 57.80% 39.33% 58.71% 52.02% 28.45%
Operating Expenses to Revenue
222.70% 142.70% 133.58% 355.37% 151.33% 86.51%
Earnings before Interest and Taxes (EBIT)
-81 -75 -197 -741 -149 -37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-74 -65 -177 -719 -137 -27
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 2.18 2.78 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 5.37 2.83 0.00 0.00
Price to Revenue (P/Rev)
7.10 3.75 7.20 1.46 4.04 6.65
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 51.86 2.91 9.25 24.00 29.92
Enterprise Value to Revenue (EV/Rev)
0.00 6.18 5.93 1.04 4.34 7.24
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.26 1.32 5.13 0.00
Long-Term Debt to Equity
0.00 0.00 0.26 1.32 5.13 0.00
Financial Leverage
0.00 -0.93 -0.50 -0.48 -0.71 -0.59
Leverage Ratio
0.00 1.32 1.36 1.59 3.35 2.33
Compound Leverage Factor
0.00 1.32 1.44 1.64 4.04 2.76
Debt to Total Capital
0.00% 0.00% 20.87% 56.94% 83.70% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 20.87% 56.94% 83.70% 0.00%
Preferred Equity to Total Capital
0.00% 235.85% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 3.51% 10.70% 27.95% 140.93%
Common Equity to Total Capital
0.00% -135.85% 75.62% 32.35% -11.64% -40.93%
Debt to EBITDA
0.00 0.00 -1.21 -0.30 -1.01 0.00
Net Debt to EBITDA
0.00 0.00 1.89 0.19 -0.01 0.00
Long-Term Debt to EBITDA
0.00 0.00 -1.21 -0.30 -1.01 0.00
Debt to NOPAT
0.00 0.00 -1.55 -0.42 -1.27 0.00
Net Debt to NOPAT
0.00 0.00 2.41 0.26 -0.01 0.00
Long-Term Debt to NOPAT
0.00 0.00 -1.55 -0.42 -1.27 0.00
Altman Z-Score
0.00 2.50 3.02 -7.11 -7.81 6.02
Noncontrolling Interest Sharing Ratio
0.00% 235.85% 43.24% 7.87% 45.55% 145.92%
Liquidity Ratios
- - - - - -
Current Ratio
0.00 5.31 10.21 11.17 5.38 3.47
Quick Ratio
0.00 4.76 9.68 10.62 4.92 2.97
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -64 -604 -72 -111 -46
Operating Cash Flow to CapEx
-10,161.90% -4,917.78% -6,760.55% -9,207.83% -21,741.23% -132.51%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 -53.54 -2.89 -3.61 -6.76
Operating Cash Flow to Interest Expense
0.00 0.00 -11.30 -7.68 -4.14 -1.93
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 -11.47 -7.76 -4.16 -3.39
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.45 0.35 0.30 0.49 0.84
Accounts Receivable Turnover
0.00 6.41 9.56 8.28 7.64 9.07
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 20.90 43.63 39.54 32.38 19.92
Accounts Payable Turnover
0.00 9.98 24.70 39.23 44.15 31.16
Days Sales Outstanding (DSO)
0.00 56.94 38.18 44.07 47.78 40.22
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 36.59 14.78 9.30 8.27 11.71
Cash Conversion Cycle (CCC)
0.00 20.36 23.40 34.76 39.51 28.51
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 11 477 27 28 39
Invested Capital Turnover
0.00 16.79 0.96 0.93 5.71 4.80
Increase / (Decrease) in Invested Capital
0.00 11 466 -451 1.78 11
Enterprise Value (EV)
0.00 593 1,390 246 681 1,173
Market Capitalization
360 360 1,688 342 633 1,077
Book Value per Share
$0.00 ($5.63) $3.37 $0.52 ($0.08) ($0.22)
Tangible Book Value per Share
$0.00 ($5.66) $1.37 $0.51 ($0.09) ($0.23)
Total Capital
0.00 163 1,024 381 165 138
Total Debt
0.00 0.00 214 217 138 0.00
Total Long-Term Debt
0.00 0.00 214 217 138 0.00
Net Debt
0.00 -152 -333 -137 1.41 -98
Capital Expenditures (CapEx)
0.58 1.32 1.89 2.07 0.59 9.84
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -0.78 5.76 6.48 1.34 -2.26
Debt-free Net Working Capital (DFNWC)
0.00 151 553 361 138 96
Net Working Capital (NWC)
0.00 151 553 361 138 96
Net Nonoperating Expense (NNE)
24 22 31 241 71 8.69
Net Nonoperating Obligations (NNO)
0.00 -152 -333 -137 1.41 -98
Total Depreciation and Amortization (D&A)
7.03 10.00 20 22 12 9.57
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -0.81% 2.46% 2.75% 0.85% -1.39%
Debt-free Net Working Capital to Revenue
0.00% 157.37% 235.82% 153.33% 88.15% 59.39%
Net Working Capital to Revenue
0.00% 157.37% 235.82% 153.33% 88.15% 59.39%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($1.30) ($3.28) ($0.76) ($0.24)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 131.99M 234.16M 245.21M 253.92M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($1.30) ($3.28) ($0.76) ($0.24)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 131.99M 234.16M 245.21M 253.92M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 232.41M 242.85M 252.05M 259.66M
Normalized Net Operating Profit after Tax (NOPAT)
-57 -53 -138 -197 -92 -30
Normalized NOPAT Margin
-112.90% -54.88% -58.88% -83.70% -58.59% -18.21%
Pre Tax Income Margin
-160.72% -77.68% -88.71% -325.70% -114.63% -26.73%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 -17.44 -29.90 -4.84 -5.42
NOPAT to Interest Expense
0.00 0.00 -12.24 -21.07 -3.55 -5.15
EBIT Less CapEx to Interest Expense
0.00 0.00 -17.61 -29.99 -4.85 -6.88
NOPAT Less CapEx to Interest Expense
0.00 0.00 -12.41 -21.15 -3.57 -6.61
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-0.06% 0.00% 0.00% 0.00% 0.00% -21.83%

Quarterly Metrics and Ratios for Blend Labs

This table displays calculated financial ratios and metrics derived from Blend Labs' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-38.20% -47.17% -47.80% -34.67% -26.67% -15.62% -6.40% -5.45% 11.32% 14.69%
EBITDA Growth
-97.15% -32.01% 11.09% 93.42% 75.02% 70.50% 75.97% 47.84% 106.38% 101.40%
EBIT Growth
-79.76% -23.20% 15.94% 92.90% 73.48% 68.26% 73.49% 47.00% 92.23% 97.08%
NOPAT Growth
-84.10% -25.54% 11.92% 92.21% 72.12% 70.90% 65.53% 63.67% 63.21% 91.83%
Net Income Growth
-73.91% -13.89% 8.59% 91.31% 68.50% 62.70% 68.78% 53.19% 93.72% 97.67%
EPS Growth
-50.00% -3.13% 12.50% 91.26% 68.42% 63.64% 67.86% 50.00% 83.33% 75.00%
Operating Cash Flow Growth
-61.40% -9.76% -1.77% 26.45% 48.72% 56.29% 91.71% 80.62% 108.02% 77.84%
Free Cash Flow Firm Growth
168.67% 0.00% 178.06% 113.96% -105.41% -104.29% -104.83% -109.26% 65.15% 29.21%
Invested Capital Growth
-93.89% -94.43% -94.99% -54.65% -16.99% 6.71% 21.22% -20.28% -9.10% 38.25%
Revenue Q/Q Growth
-15.54% -22.71% -12.74% 14.67% -5.19% -11.05% -3.20% 15.83% 11.62% -8.36%
EBITDA Q/Q Growth
73.55% 42.91% 20.93% 44.89% -0.41% 32.58% 35.60% -19.65% 112.27% -85.22%
EBIT Q/Q Growth
73.15% 41.84% 20.46% 42.81% -0.23% 30.39% 33.57% -14.35% 85.30% 73.86%
NOPAT Q/Q Growth
72.45% 42.12% 18.26% 40.23% 1.42% 39.59% 3.16% 37.01% 0.15% 86.58%
Net Income Q/Q Growth
72.18% 38.65% 18.72% 37.32% -0.80% 27.36% 31.98% 6.01% 86.47% 73.05%
EPS Q/Q Growth
72.33% 42.11% 15.15% 35.71% 0.00% 33.33% 25.00% 0.00% 66.67% 0.00%
Operating Cash Flow Q/Q Growth
-7.97% 6.24% 1.44% 26.29% 24.73% 20.07% 81.31% -72.34% 131.14% -320.91%
Free Cash Flow Firm Q/Q Growth
371.68% 6.50% 3.56% -95.34% -205.20% 15.40% 17.25% 91.07% -295.96% -71.81%
Invested Capital Q/Q Growth
-63.22% -12.08% -9.60% 55.15% -32.68% 13.03% -17.60% 2.03% -23.24% 71.90%
Profitability Metrics
- - - - - - - - - -
Gross Margin
38.14% 33.67% 42.46% 54.87% 54.35% 54.64% 51.91% 53.55% 57.53% 59.72%
EBITDA Margin
-221.74% -163.77% -148.39% -71.32% -75.53% -57.25% -38.09% -39.35% 4.33% 0.70%
Operating Margin
-234.60% -175.66% -164.55% -85.77% -89.18% -60.57% -60.59% -32.95% -29.48% -4.32%
EBIT Margin
-228.67% -172.07% -156.83% -78.22% -82.69% -64.72% -44.42% -43.85% -5.77% -1.65%
Profit (Net Income) Margin
-239.82% -190.35% -177.29% -96.90% -103.03% -84.13% -59.13% -47.98% -5.81% -1.71%
Tax Burden Percent
100.01% 100.59% 100.11% 100.13% 100.11% 99.76% 100.20% 100.12% 100.69% 103.81%
Interest Burden Percent
104.87% 109.98% 112.93% 123.73% 124.46% 130.32% 132.85% 109.28% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-171.02% -114.82% -92.02% -179.22% -369.08% -242.10% -246.55% -104.77% -135.02% -14.49%
ROIC Less NNEP Spread (ROIC-NNEP)
-156.21% -102.57% -79.63% -168.05% -353.44% -219.93% -230.35% -91.74% -144.47% -15.61%
Return on Net Nonoperating Assets (RNNOA)
80.98% 49.54% 33.96% 118.12% 279.97% 156.63% 132.63% 64.03% 107.99% 9.20%
Return on Equity (ROE)
-90.04% -65.27% -58.06% -61.10% -89.11% -85.47% -113.92% -40.74% -27.03% -5.29%
Cash Return on Invested Capital (CROIC)
0.00% -28.46% -24.38% -280.13% -511.69% -404.63% -324.67% -170.93% -194.20% -134.92%
Operating Return on Assets (OROA)
-74.83% -52.38% -43.79% -29.36% -33.34% -31.78% -23.37% -24.89% -3.59% -1.39%
Return on Assets (ROA)
-78.48% -57.95% -49.50% -36.38% -41.54% -41.31% -31.11% -27.24% -3.61% -1.44%
Return on Common Equity (ROCE)
-82.94% -60.14% -52.83% -48.69% -60.90% -46.54% -32.36% 0.77% 6.17% 2.43%
Return on Equity Simple (ROE_SIMPLE)
-429.40% 0.00% -1,061.85% -779.98% -3,670.47% 0.00% 375.66% 246.93% 147.35% 0.00%
Net Operating Profit after Tax (NOPAT)
-91 -53 -43 -26 -25 -15 -15 -9.34 -9.32 -1.25
NOPAT Margin
-164.22% -122.96% -115.18% -60.04% -62.42% -42.40% -42.41% -23.07% -20.63% -3.02%
Net Nonoperating Expense Percent (NNEP)
-14.81% -12.25% -12.39% -11.17% -15.64% -22.17% -16.20% -13.03% 9.45% 1.12%
Return On Investment Capital (ROIC_SIMPLE)
- -15.47% - - - -12.85% - - - 2.22%
Cost of Revenue to Revenue
61.86% 66.33% 57.54% 45.13% 45.65% 45.36% 48.09% 46.45% 42.47% 40.28%
SG&A Expenses to Revenue
58.06% 78.08% 55.39% 45.89% 38.97% 40.28% 39.87% 30.94% 29.08% 26.46%
R&D to Revenue
61.86% 77.71% 70.33% 51.60% 46.38% 39.93% 40.58% 31.91% 22.41% 21.40%
Operating Expenses to Revenue
272.73% 209.34% 207.01% 140.64% 143.53% 115.20% 112.50% 86.50% 87.01% 64.04%
Earnings before Interest and Taxes (EBIT)
-127 -74 -59 -33 -34 -23 -16 -18 -2.61 -0.68
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-123 -70 -55 -31 -31 -21 -13 -16 1.96 0.29
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.96 2.78 3.39 5.60 53.54 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
2.99 2.83 3.49 5.90 80.63 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.90 1.46 1.20 1.30 2.06 4.04 5.30 3.92 6.08 6.65
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
12.37 9.25 8.10 6.09 14.18 24.00 30.36 22.58 44.98 29.92
Enterprise Value to Revenue (EV/Rev)
1.37 1.04 0.97 1.27 2.17 4.34 5.72 4.41 6.55 7.24
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
1.00 1.32 1.92 2.58 4.29 5.13 12.21 0.04 0.01 0.00
Long-Term Debt to Equity
1.00 1.32 1.92 2.58 4.29 5.13 12.21 0.04 0.01 0.00
Financial Leverage
-0.52 -0.48 -0.43 -0.70 -0.79 -0.71 -0.58 -0.70 -0.75 -0.59
Leverage Ratio
1.53 1.59 1.64 2.36 3.05 3.35 4.69 2.42 2.66 2.33
Compound Leverage Factor
1.61 1.74 1.85 2.92 3.79 4.36 6.23 2.64 2.66 2.33
Debt to Total Capital
50.11% 56.94% 65.74% 72.06% 81.10% 83.70% 92.43% 3.63% 0.68% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
50.11% 56.94% 65.74% 72.06% 81.10% 83.70% 92.43% 3.63% 0.68% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
9.16% 10.70% 12.70% 14.32% 16.57% 27.95% 30.33% 128.32% 134.85% 140.93%
Common Equity to Total Capital
40.73% 32.35% 21.56% 13.63% 2.33% -11.64% -22.76% -31.95% -35.53% -40.93%
Debt to EBITDA
-0.31 -0.30 -0.31 -0.78 -1.17 -1.01 -1.53 -0.06 -0.02 0.00
Net Debt to EBITDA
0.26 0.19 0.13 0.17 0.14 -0.01 -0.18 1.33 2.42 0.00
Long-Term Debt to EBITDA
-0.31 -0.30 -0.31 -0.78 -1.17 -1.01 -1.53 -0.06 -0.02 0.00
Debt to NOPAT
-0.42 -0.42 -0.42 -1.03 -1.49 -1.27 -1.79 -0.08 -0.02 0.00
Net Debt to NOPAT
0.36 0.26 0.17 0.22 0.18 -0.01 -0.21 1.66 2.37 0.00
Long-Term Debt to NOPAT
-0.42 -0.42 -0.42 -1.03 -1.49 -1.27 -1.79 -0.08 -0.02 0.00
Altman Z-Score
-1.25 -2.02 -2.94 -3.42 -3.92 -5.80 -5.66 -1.87 3.08 6.68
Noncontrolling Interest Sharing Ratio
7.89% 7.87% 9.02% 20.30% 31.66% 45.55% 71.59% 101.90% 122.83% 145.92%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
10.29 11.17 8.77 8.87 7.69 5.38 3.75 3.43 3.24 3.47
Quick Ratio
9.71 10.62 8.19 8.23 7.19 4.92 3.44 3.18 2.93 2.97
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
374 398 412 19 -20 -17 -20 -1.78 -7.04 -12
Operating Cash Flow to CapEx
-11,319.51% -10,334.72% -15,346.38% -20,229.41% -83,506.45% -25,232.93% -196.95% -357.04% 60.49% -177.68%
Free Cash Flow to Firm to Interest Expense
60.69 54.17 54.46 2.42 -2.46 -2.41 -3.91 -1.08 0.00 0.00
Operating Cash Flow to Interest Expense
-8.20 -6.44 -6.16 -4.33 -3.15 -2.92 -0.76 -4.04 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-8.27 -6.50 -6.20 -4.35 -3.16 -2.93 -1.14 -5.18 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.33 0.30 0.28 0.38 0.40 0.49 0.53 0.57 0.62 0.84
Accounts Receivable Turnover
9.36 8.28 7.51 6.83 6.94 7.64 8.11 7.43 8.83 9.07
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
37.84 39.54 35.57 31.80 31.18 32.38 27.12 24.17 22.11 19.92
Accounts Payable Turnover
34.88 39.23 61.45 32.07 37.56 44.15 37.09 33.32 35.73 31.16
Days Sales Outstanding (DSO)
39.00 44.07 48.59 53.43 52.59 47.78 44.99 49.13 41.31 40.22
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
10.46 9.30 5.94 11.38 9.72 8.27 9.84 10.96 10.22 11.71
Cash Conversion Cycle (CCC)
28.53 34.76 42.65 42.04 42.87 39.51 35.15 38.17 31.10 28.51
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
30 27 24 37 25 28 29 30 23 39
Invested Capital Turnover
1.04 0.93 0.80 2.99 5.91 5.71 5.81 4.54 6.54 4.80
Increase / (Decrease) in Invested Capital
-465 -451 -455 -45 -5.14 1.78 5.10 -7.56 -2.28 11
Enterprise Value (EV)
374 246 195 227 356 681 884 671 1,026 1,173
Market Capitalization
519 342 242 231 337 633 819 596 953 1,077
Book Value per Share
$0.75 $0.52 $0.29 $0.17 $0.03 ($0.08) ($0.14) ($0.18) ($0.20) ($0.22)
Tangible Book Value per Share
$0.74 $0.51 $0.29 $0.16 $0.02 ($0.09) ($0.15) ($0.19) ($0.20) ($0.23)
Total Capital
431 381 331 303 270 165 157 142 140 138
Total Debt
216 217 218 218 219 138 145 5.17 0.96 0.00
Total Long-Term Debt
216 217 218 218 219 138 145 5.17 0.96 0.00
Net Debt
-185 -137 -89 -47 -26 1.41 17 -107 -116 -98
Capital Expenditures (CapEx)
0.45 0.46 0.30 0.17 0.03 0.08 1.96 1.87 3.43 2.58
Debt-free, Cash-free Net Working Capital (DFCFNWC)
8.89 6.48 3.38 8.90 1.42 1.34 -11 -12 -16 -2.26
Debt-free Net Working Capital (DFNWC)
410 361 310 274 246 138 117 101 101 96
Net Working Capital (NWC)
410 361 310 274 246 138 117 101 101 96
Net Nonoperating Expense (NNE)
42 29 23 16 16 15 5.84 10 -6.70 -0.54
Net Nonoperating Obligations (NNO)
-185 -137 -89 -47 -26 1.41 17 -107 -116 -98
Total Depreciation and Amortization (D&A)
3.83 3.55 3.15 2.96 2.91 2.70 2.21 1.82 4.56 0.97
Debt-free, Cash-free Net Working Capital to Revenue
3.25% 2.75% 1.68% 4.99% 0.87% 0.85% -7.16% -7.63% -9.97% -1.39%
Debt-free Net Working Capital to Revenue
149.84% 153.33% 154.34% 153.96% 150.66% 88.15% 75.73% 66.39% 64.55% 59.39%
Net Working Capital to Revenue
149.84% 153.33% 154.34% 153.96% 150.66% 88.15% 75.73% 66.39% 64.55% 59.39%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.57) ($0.33) ($0.28) ($0.18) ($0.18) ($0.12) ($0.09) ($0.09) ($0.03) ($0.03)
Adjusted Weighted Average Basic Shares Outstanding
235.27M 234.16M 241.44M 244.26M 246.41M 245.21M 250.93M 253.07M 254.91M 253.92M
Adjusted Diluted Earnings per Share
($0.57) ($0.33) ($0.28) ($0.18) ($0.18) ($0.12) ($0.09) ($0.09) ($0.03) ($0.03)
Adjusted Weighted Average Diluted Shares Outstanding
235.27M 234.16M 241.44M 244.26M 246.41M 245.21M 250.93M 253.07M 254.91M 253.92M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
237.70M 242.85M 243.85M 245.89M 248.20M 252.05M 252.38M 254.24M 255.93M 259.66M
Normalized Net Operating Profit after Tax (NOPAT)
-46 -51 -34 -24 -19 -15 -14 -9.19 -5.01 -1.17
Normalized NOPAT Margin
-83.54% -118.12% -91.22% -56.20% -46.69% -41.05% -40.45% -22.71% -11.08% -2.82%
Pre Tax Income Margin
-239.79% -189.24% -177.10% -96.78% -102.92% -84.34% -59.01% -47.92% -5.77% -1.65%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-20.55 -10.02 -7.74 -4.21 -4.09 -3.30 -3.04 -10.77 0.00 0.00
NOPAT to Interest Expense
-14.76 -7.16 -5.68 -3.23 -3.09 -2.16 -2.91 -5.67 0.00 0.00
EBIT Less CapEx to Interest Expense
-20.63 -10.08 -7.78 -4.24 -4.09 -3.31 -3.43 -11.90 0.00 0.00
NOPAT Less CapEx to Interest Expense
-14.83 -7.22 -5.72 -3.26 -3.09 -2.17 -3.29 -6.80 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -21.83%

Frequently Asked Questions About Blend Labs' Financials

When does Blend Labs's fiscal year end?

According to the most recent income statement we have on file, Blend Labs' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Blend Labs' net income changed over the last 5 years?

Blend Labs' net income appears to be on an upward trend, with a most recent value of -$43.42 million in 2024, falling from -$81.45 million in 2019. The previous period was -$179.88 million in 2023.

What is Blend Labs's operating income?
Blend Labs's total operating income in 2024 was -$49.62 million, based on the following breakdown:
  • Total Gross Profit: $90.54 million
  • Total Operating Expenses: $140.16 million
How has Blend Labs revenue changed over the last 5 years?

Over the last 5 years, Blend Labs' total revenue changed from $50.67 million in 2019 to $162.02 million in 2024, a change of 219.7%.

How much debt does Blend Labs have?

Blend Labs' total liabilities were at $40.33 million at the end of 2024, a 77.5% decrease from 2023, and a 23.0% decrease since 2020.

How much cash does Blend Labs have?

In the past 4 years, Blend Labs' cash and equivalents has ranged from $30.96 million in 2023 to $213.08 million in 2021, and is currently $42.24 million as of their latest financial filing in 2024.

How has Blend Labs' book value per share changed over the last 5 years?

Over the last 5 years, Blend Labs' book value per share changed from 0.00 in 2019 to -0.22 in 2024, a change of -22.0%.



This page (NYSE:BLND) was last updated on 4/28/2025 by MarketBeat.com Staff
From Our Partners